Fluorine-containing drugs approved by the FDA in 2019

Haibo Mei, Attila Márió Remete, Yupiao Zou, Hiroki Moriwaki, Santos Fustero, Lorand Kiss, Vadim A. Soloshonok, Jianlin Han

Research output: Article

2 Citations (Scopus)

Abstract

Eleven new fluorine-containing FDA-approved drugs have been profiled and details of their discovery and preparation are discussed. Therapeutic areas include schizophrenia, migraine, multiple sclerosis, insomnia, rheumatoid arthritis, anti-tuberculosis, breast cancer, lymphoma kinase inhibitor, serotonin receptor antagonist. New pharmaceuticals feature four examples of aromatic fluorine, three aromatic CF3 group, three aliphatic CF3 and one compound with aromatic CF3O group. Furthermore, among the new compounds, six are chiral and seven are derived from tailor-made amino acids.

Original languageEnglish
JournalChinese Chemical Letters
DOIs
Publication statusAccepted/In press - jan. 1 2020

ASJC Scopus subject areas

  • Chemistry(all)

Fingerprint Dive into the research topics of 'Fluorine-containing drugs approved by the FDA in 2019'. Together they form a unique fingerprint.

  • Cite this

    Mei, H., Remete, A. M., Zou, Y., Moriwaki, H., Fustero, S., Kiss, L., Soloshonok, V. A., & Han, J. (Accepted/In press). Fluorine-containing drugs approved by the FDA in 2019. Chinese Chemical Letters. https://doi.org/10.1016/j.cclet.2020.03.050